SGCA
GMED icon

Steel Grove Capital Advisors’s Globus Medical GMED Stock Holding History

Steel Grove Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,143
Closed -$274K – 225
2025
Q4 		$274K Buy
+3,143
New +$239K 0.03% 160

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steel Grove Capital Advisors's GMED Position: Q1 2026 in Review

Steel Grove Capital Advisors sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 3,143 shares — an estimated $274K sold.

Steel Grove Capital Advisors first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $274K in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Steel Grove Capital Advisors reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Steel Grove Capital Advisors sold 3,143 Globus Medical shares in Q1 2026, an estimated $274K.
  • Steel Grove Capital Advisors first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
  • Steel Grove Capital Advisors's Globus Medical position peaked at $274K in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Steel Grove Capital Advisors's 13F filing for Q1 2026, filed 7 May 2026.